BioAge Labs Inc. (BIOA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for BioAge Labs Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$5.94
+8.59% today
Market cap
$251M
Overall quality
38/100
Kronos AI 30-day
+116.2%
8 of 8 simulated paths end higher
BioAge Labs Inc. (BIOA) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $251M. It trades at $5.94, up 8.59% today. Its overall quality score is 38 out of 100, ranked against the whole US market. 10 analysts' average target of $32.56 implies +448.1% from today's price. Kronos AI's 30-day forecast is +116.2% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $32.56 |
| Low – high | $8.00 – $73.00 |
| Analysts | 10 |
| Upside to average | +448.1% |
Kronos AI 30-day forecast
| Expected close | $11.83 (+116.2%) |
| Likely range | +83.3% … +184.8% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 11 |
| Solvency | 61 |
| Growth | 43 |
| Overall | 38 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.